Instituto Nacional del Cáncer Rosa Emilia Sánchez Pérez de Tavares

Name

Instituto Nacional del Cáncer Rosa Emilia Sánchez Pérez de Tavares

Legal name

Instituto Nacional del Cáncer Rosa Emilia Sánchez Pérez de Tavares

Website

https://incart.gob.do

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Specialty Cancer Hospital Services

NAICS

General Medical and Surgical Hospitals (6221), Ambulatory Health Care Services (621), Medical Laboratories (621511)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Specialty Outpatient Facilities, Nec (8093), Services-Medical Laboratories (8071)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB), Gastrointestinal Oncology (HLAKAFAK)

Keywords

• Cancer treatment services
• Oncology diagnostics
• Radiation therapy
• Pediatric oncology
• Cancer research

Headquarters

HQ city

Santo Domingo

HQ country

Dominican Republic

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Distribution channels3 records

Marketing channels4 records

Core offering

INCART is the Dominican Republic's national reference oncology center, providing comprehensive cancer diagnosis, treatment, and supportive care. Services include laboratory testing, diagnostic imaging, hospitalization, emergency care, radiation oncology, chemotherapy, surgical oncology, nuclear medicine, and pediatric oncology. The institute also operates an on-site cyclotron and radiopharmacy, an anatomical pathology center, a blood bank, social work services, psychological support groups, and a high-cost medication program.

Product overview

INCART is a national oncology institute providing comprehensive cancer care services in the Dominican Republic. The institution offers a unified platform of diagnostic, treatment, and support services organized around cancer care delivery. Core clinical services include laboratory testing, diagnostic imaging, hospitalization, emergency care, and radiation oncology. Specialized units include the Pediatric Oncology Unit Uniendo Voluntades (opened 2024), Anatomical Pathology Center, Ciclotrón-Radiofarmacia Center, and Blood Bank. Support services encompass high-cost medication programs, social work, psychological support groups, and medical research/training programs. The institute operates as a comprehensive cancer center integrating prevention, diagnosis, treatment, and follow-up care.

Differentiator

Problem solved

Functional benefit

Brands

• Centro Oncológico Pediátrico (COP): Pediatric oncology center providing cancer treatment for children
• Uniendo Voluntades
• Programa de Medicamentos de Alto Costo

Products and services

• Laboratory Services (Exámenes de Laboratorio) Clinical laboratory testing services supporting cancer diagnosis, staging, and treatment monitoring for adult and pediatric patients.
• Imaging Studies (Estudios de Imágenes) Diagnostic imaging including radiography, tomography, and molecular imaging for cancer detection and staging.
• Hospitalization (Hospitalización) Inpatient cancer care including surgery, chemotherapy administration, treatment recovery, and continuous monitoring.
• Emergency Services (Emergencias) 24/7 emergency medical care for oncology patients presenting with acute complications or treatment-related events.
• Radiation Oncology Center (Centro de Radioncología) Radiation therapy treatment using linear accelerator technology for solid tumor management.
• Pediatric Oncology Unit - Uniendo Voluntades Specialized pediatric oncology care offering diagnosis, treatment, intensive care, surgery, and day hospital services for children and adolescents with cancer.
• High-Cost Medication Program (Programa de Medicamentos de Alto Costo) Program providing access to expensive, quality, safe, and cost-effective oncology medications for cancer patients.
• Anatomical Pathology Center (Centro de Anatomía Patológica) Pathology laboratory performing biopsies, immunohistochemistry, genetic expression profiling, and DNA sequencing for cancer diagnosis and treatment planning.
• Ciclotrón - Radiofarmacia Center On-site cyclotron and radiopharmacy facility producing radiopharmaceuticals, including 18F-FDG for PET/CT diagnostics and therapeutic radiopharmaceuticals.
• Blood Bank (Banco de Sangre) Blood donation and transfusion services including apheresis donations for platelets, red blood cells, and plasma for oncology patients.
• Oncology Support Groups Weekly psychological support groups providing psychoeducation, emotional support, family guidance, and spiritual support for oncology patients and caregivers.

Quantifiable outcome

• Childhood cancer curable in 70% of cases when detected early

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Eight partnerships are on record, tiered core and minor.

• Instituto Dermatológico Dominicano y Cirugía de Piel Dr. Huberto Bogaert Diaz (IDCP)coreStrategic or Co-development Partner · 15 May 2024Collaboration and referral agreement between IDCP and INCART for improving skin cancer treatment and prevention. Enables joint academic activities for healthcare professionals and community service. Allows rotation of medical residents between institutions for training in skin cancer treatment.
• Centro de Gastroenterología Ciudad Sanitaria Dr. Luis E. AybarcoreStrategic or Co-development Partner · 29 January 2021Mutual collaboration agreement for patient referral. Centro de Gastroenterología refers cancer-diagnosed patients to INCART for specialized oncology treatment and procedures.
• Moffitt Cancer CentercoreStrategic or Co-development Partner · 6 September 2018International collaboration through scientific update events. Visits by Moffitt medical staff including the Medical Director and neurosurgeon for knowledge exchange on breast cancer and neuro-oncology.
• MD Anderson Cancer CentercoreStrategic or Co-development Partner · 25 October 2017Second joint meeting focused on immunotherapy in lung cancer. Specialist exchange and knowledge sharing on latest cancer treatment updates and trends. Working toward INCART becoming a sister oncology center in the Caribbean.
• Raquel Arbaje / Uniendo VoluntadescoreStrategic or Co-development PartnerFirst Lady of the Dominican Republic supporting the pediatric oncology unit. Initiative to create a model unit for pediatric cancer care with planned expansion to 40 beds, 6 consultorios, 2 quirófanos, recreation area, and procedure areas.
• Ministerio de Salud, Servicio Nacional de Salud, OPS/OMScoreStrategic or Co-development PartnerCollaborative partnership for the Plan Nacional de Cáncer Infantil (PENCI-RD) 2023-2030. Technical committee for childhood cancer management including early detection, treatment protocols, and national coordination.
• SISALRILminorStrategic or Co-development PartnerTechnical table integration to analyze insurance benefits and potential new coverage options for childhood cancer treatment.
• Fundación Amigos Contra el Cáncer Infantil (FACCI)coreStrategic or Co-development PartnerDominican link to St. Jude Children's Research Hospital. Provides support to pediatric oncology patients at INCART and Hospital Infantil Dr. Robert Reid Cabral. Coordinates with St. Jude for resources and treatment protocols.

Scale indicators4 records

Recent moves8 records

Expansion highlights6 records

Others

• St. Jude Children's Research Hospital: Global pediatric oncology reference center linked to INCART through FACCI. Functions as a pediatric oncology protocol and resource partner rather than a competitor; relevant as an indirect capability-shaping peer.
• Moffitt Cancer Center: US NCI-designated cancer center with which INCART maintains a knowledge-exchange partnership (breast and neuro-oncology). Functions as a clinical affiliate and capability-building partner rather than a peer competitor.
• MD Anderson Cancer Center: INCART's strategic knowledge-exchange partner and global benchmark for comprehensive cancer care. Listed as OTHERS because it is not a direct competitor; it functions as a clinical/training affiliate and aspirational reference rather than a market peer.

Broad incumbents

• Hospital Israelita Albert Einstein: Large Brazilian private hospital system with a major oncology program including advanced diagnostics and research. Comparable to INCART as a leading cancer care provider in Latin America, though broader in scope (general hospital) and privately operated.
• Hospital Italiano de Buenos Aires: Argentinian tertiary hospital with a significant oncology service line and research/teaching activity. Comparable to INCART as a Latin American tertiary cancer care provider, though broader in scope and private.

Direct peers

• Instituto Nacional de Cancerología (Mexico): Mexico's national cancer reference hospital, a public specialty oncology institution delivering comprehensive cancer care, research and teaching. Most direct comparable to INCART in mission, public-sector ownership, and national reference center status in a Latin American country.
• A.C. Camargo Cancer Center: Major Brazilian specialty oncology hospital combining diagnosis, treatment, research and education. Directly comparable to INCART in being a dedicated comprehensive cancer center with academic/research components.
• Instituto Nacional de Cancerología (Colombia): Colombia's national cancer institute, a public-sector specialty oncology center providing multidisciplinary cancer treatment, research, and residency training. Highly comparable to INCART in scope, public ownership model, and Latin American national reference role.
• Hospital de Câncer de Barretos: Leading Brazilian comprehensive cancer hospital known for high-volume oncology care, pediatric oncology, and research. Comparable to INCART as a full-service specialty cancer hospital with outreach and training programs.
• Hospital Oncológico de Caracas: Venezuelan national oncology hospital providing public-sector cancer care. Comparable to INCART as a publicly operated, national-level specialty oncology hospital in Latin America/Caribbean.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/incartrd
• YouTubeyoutube.com/channel/UCqG8E1u7JnDfK81ht__nkdg/featured
• Facebookfacebook.com/incartrd
• Instagraminstagram.com/incartrd
• LinkedInlinkedin.com/company/incartrd

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Instituto Nacional del Cáncer Rosa Emilia Sánchez Pérez de Tavares